These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 4834542)

  • 1. Diphenylhydantoin concentrations in saliva.
    Bochner F; Hooper WD; Sutherland JM; Eadie MJ; Tyrer JH
    Arch Neurol; 1974 Jul; 31(1):57-9. PubMed ID: 4834542
    [No Abstract]   [Full Text] [Related]  

  • 2. Levels of 5,5-diphenylhydantoin and its major metabolite in human serum, saliva, and hyperplastic gingiva.
    Conard GJ; Jeffay H; Boshes L; Steinberg AD
    J Dent Res; 1974; 53(6):1323-9. PubMed ID: 4529919
    [No Abstract]   [Full Text] [Related]  

  • 3. Phenytoin and IgA concentrations in plasma and saliva in epileptic children.
    Modéer T; Tomson G; Falk O; Rane A
    Acta Paediatr Scand; 1981; 70(3):373-8. PubMed ID: 7246128
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparison of plasma and saliva levels of carbamazepine and phenytoin as monotherapy.
    Callaghan N; Goggin T
    Ir J Med Sci; 1984 May; 153(5):170-3. PubMed ID: 6480316
    [No Abstract]   [Full Text] [Related]  

  • 5. Parotid and whole saliva in the prediction of serum total and free phenytoin concentrations.
    Anavekar SN; Saunders RH; Wardell WM; Shoulson I; Emmings FG; Cook CE; Gringeri AJ
    Clin Pharmacol Ther; 1978 Dec; 24(6):629-37. PubMed ID: 710022
    [No Abstract]   [Full Text] [Related]  

  • 6. Comparison of phenytoin determinations in plasma, plasma dialysate and saliva for control of antiepileptic therapy in children.
    Brügmann G; Kleinau E; Nolte R; Petruch F
    Klin Wochenschr; 1979 Jan; 57(2):93-4. PubMed ID: 762949
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Application of drug monitoring with saliva--the influence of phenytoin upon the salivary inorganic constituents].
    Watanabe S; Igarashi S; Ichida T
    Rinsho Byori; 1986 Mar; 34(3):254-61. PubMed ID: 3712786
    [No Abstract]   [Full Text] [Related]  

  • 8. Phenytoin-valproate interaction: importance of saliva monitoring in epilepsy.
    Knott C; Hamshaw-Thomas A; Reynolds F
    Br Med J (Clin Res Ed); 1982 Jan; 284(6308):13-6. PubMed ID: 6797618
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intravenous valproate: effects on plasma and saliva phenytoin levels.
    Pisani FD; Di Perri RG
    Neurology; 1981 Apr; 31(4):467-70. PubMed ID: 6783979
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Two-fold interindividual variation in plasma protein binding of phenytoin in patients with epilepsy.
    Barth N; Alván G; Borgå O; Sjöqvist F
    Clin Pharmacokinet; 1976; 1(6):444-52. PubMed ID: 1024769
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gingival hyperplasia and diphenylhydantoin.
    Ciancio SG; Yaffe SJ; Catz CC
    J Periodontol; 1972 Jul; 43(7):411-4. PubMed ID: 4504524
    [No Abstract]   [Full Text] [Related]  

  • 12. Salivary phenytoin concentrations in geriatric patients.
    Umstead GS; McKernan TM
    Clin Pharm; 1982; 1(1):54-8. PubMed ID: 7184669
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Confirmation of a workable relationship between saliva and plasma phenytoin concentrations in man as measured by radioimmunoassay].
    Alric R; Blayac JP; Negre C; Baldy-Moulinier M; Passouant P
    Therapie; 1978; 33(3):333-9. PubMed ID: 684685
    [No Abstract]   [Full Text] [Related]  

  • 14. [Relationship between gingival hyperplasia and transfer of phenytoin to saliva and serum].
    Bostanci H; Aksoy N; Timlioğlu O
    Ankara Univ Hekim Fak Derg; 1988 May; 15(2):193-6. PubMed ID: 3271157
    [No Abstract]   [Full Text] [Related]  

  • 15. Aberrantly high phenytoin concentrations in saliva. Precaution in monitoring phenytoin concentrations in whole saliva.
    Paxton JW; Foote S
    Br J Clin Pharmacol; 1979 Nov; 8(5):508-9. PubMed ID: 508560
    [No Abstract]   [Full Text] [Related]  

  • 16. Saliva carbamazepine and phenytoin level monitoring.
    Rylance GW; Moreland TA
    Arch Dis Child; 1981 Aug; 56(8):637-40. PubMed ID: 7271302
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Salivary phenytoin radioimmunoassay. A simple method of the assessment of non-protein bound drug concentrations.
    Paxton JW; Rowell F; Ratcliffe JG; Lambie DG; Nanda R; Melville ID; Johnson RH
    Eur J Clin Pharmacol; 1977; 11(1):71-4. PubMed ID: 832662
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diphenylhydantoin gingival hyperplasia in Macaca arctoides: a new human model.
    Staple PH; Reed MJ; Mashimo PA
    J Periodontol; 1977 Jun; 48(6):325-36. PubMed ID: 405470
    [No Abstract]   [Full Text] [Related]  

  • 19. Salivary phenytoin concentrations in epilepsy and in chronic renal failure.
    Reynolds F; Ziroyanis PN; Jones NF; Smith SE
    Lancet; 1976 Aug; 2(7982):384-6. PubMed ID: 73850
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Gingival hyperplasia and diphenylhydantoin].
    Barone GP; Arata E; Salmeri S; Patrone M
    Parodontol Stomatol (Nuova); 1984; 23(3 Suppl 3):149-55. PubMed ID: 6443491
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.